9:00am Chair Introduction

Tom Bollenbach, Chief Technology Officer, Advanced Regenerative Manufacturing Institute (ARMI)

9:05am Presentation: Enabling a fast-to-clinic to clinic approach with rapid scale-up of a highly customized lentiviral vector drug product

• VivoVec particle design for in vivo CAR-T applications
• Leveraging the manufacturing platform for fast to clinic approaches
• Process establishment and robustness at 50L scale

Branden Salinas, Senior Director, Manufacturing Sciences and Technology, Umoja Biopharma

9:20am Presentation: Accelerate Speed to Clinic and Improve Success Rate in Cell/Gene Therapy Development

Zhimei Du, Vice President, Translational Research and Early Development, Landmark Bio

9:35am Presentation: Addressing the Cell Multiplexing Problem with miCAR Cell Engineering

Sven Kili, Chief Executive Officer, Antion Biosciences

9:50am Presentation: Scaling ATMPs in a multi-therapy, multi-stakeholder, multi-site environment

• How can digital solutions be used to increase access to ATMPs ?
• How can clinics deal with multiple cell and gene therapies from multiple providers?
• How do you improve communication and coordination between multiple providers to ensure patient safety?

Najib Rehman, Digital Automation Lead, ATMPS Ltd – Hataali

10:05am Closing Panel with Q&A

With all session participants